Mercantile Bank (MBWM) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

Mercantile Bank Corp (MBWM) Prix de l'Action, Cotation, Actualités et Historique

MBWMNASDAQ

Trade with Public

Trade with Public

$59.50

1.081.85%

Dern. MÀJ: Oct 19, 6:11 PM

$59.50

1.081.85%

AperçuActualités Prévisions de résultats Objectifs de cours Données financières Sentiment Actionnariat Dividendes Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

-

Clôture

-

Volume / Moy.

49.00 / 118.97K

Fourchette Journalière

- - -

Plage 52 Sem.

42.88 - 62.95

Capitalisation Boursière

$1.03B

Ratio P/E

10.27

Rendement des Dividendes

2.67%

Échange

NASDAQ

RSI

57

Intérêt à Découvert

3.72%

Jours pour Couvrir

5.53

Actualités Récentes de Mercantile Bank Corporation

AST SpaceMobile, SBC Medical Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures fall around 250 points on Monday. ASTS shares drop 13.5% after satellite placed in lower-than-planned orbit. Other stocks decline in pre-market trading.

Avi Kapoor

Regional Bank Gains Hit Levels Unseen Since Silicon Valley Bank's Failure As Investor Sentiment Shifts To Small-Cap Names

US regional banks gain as investors rotate from large-cap to small-cap stocks, with the SPDR S&P Regional Banking ETF rallying 4.5% on Tuesday.

Piero Cingari

Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.

Lisa Levin

Morgan Stanley, Charles Schwab, Bank of America, And Other Big Stocks Moving Higher On Tuesday

U.S. stocks traded mostly higher, with the Dow Jones gaining over 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Tesla To $370? Plus HC Wainwright Slashes PT On This Stock By 67%

HC Wainwright & Co. cut KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) price target from $48 to $16. KalVista Pharmaceuticals shares fell 1.8% to $5.06 in pre-market trading.

Lisa Levin

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

72.33M

Flux de Trésorerie d'Investissement (TTM)

-62.63M

Flux de Trésorerie de Financement (TTM)

35.15M

Flux de Trésorerie Libre (TTM)

68.20M

Dépenses en Capital (TTM)

-4.13M

Variation Nette de la Trésorerie (TTM)

44.86M

Tendances et prévisions des analystes

1

juin

1

1

juil.

Acheter

Conserver

Vendre

Vente forte

Évaluation et prévisions des analystes

3.1

Conserver

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

-

Ratio P/E (TTM)

10.27

Ratio P/E (FWD)

-

Ratio PEG (TTM)

-

Ratio P/S (TTM)

3.75

Ratio P/B (TTM)

1.34

Rendement des Bénéfices % (TTM)

9.74%

Rendement des Bénéfices % (FWD)

-

EV / EBITDA (TTM)

-

Prix / EBITDA (TTM)

-

Prix / Flux de Trésorerie Libre (TTM)

14.35

Valeur Comptable / Action

$43.68

Dette Entreprise

Dette Totale

$471.51M

Dette à Long Terme

$370.57M

Émission de Dette à Long Terme (TTM)

$60.00M

Remboursement de la Dette à Long Terme (TTM)

-$85.90M

Trésorerie Totale

$340.93M

Dette sur Capitaux Propres

0.62

Émission de Dette (TTM)

-$25.90M

Remboursement de la Dette (TTM)

-$85.90M